{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:06:07Z","timestamp":1789671967820,"version":"4.0.1"},"reference-count":152,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Culture, Sports and Science and Technology of Japan","award":["19710167"],"award-info":[{"award-number":["19710167"]}]},{"name":"Ministry of Education, Culture, Sports and Science and Technology of Japan","award":["24501354"],"award-info":[{"award-number":["24501354"]}]},{"name":"Ministry of Health, Labour and Welfare of Japan","award":["19710167"],"award-info":[{"award-number":["19710167"]}]},{"name":"Ministry of Health, Labour and Welfare of Japan","award":["24501354"],"award-info":[{"award-number":["24501354"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (NASH) are chronic hepatic conditions leading to hepatocellular carcinoma (HCC) development. According to the recent \u201cmultiple-parallel-hits hypothesis\u201d, NASH could be caused by abnormal metabolism, accumulation of lipids, mitochondrial dysfunction, and oxidative and endoplasmic reticulum stresses and is found in obese and non-obese patients. Recent translational research studies have discovered new proteins and signaling pathways that are involved not only in the development of NAFLD but also in its progression to NASH, cirrhosis, and HCC. Nevertheless, the mechanisms of HCC developing from precancerous lesions have not yet been fully elucidated. Now, it is of particular importance to start research focusing on the discovery of novel molecular pathways that mediate alterations in glucose and lipid metabolism, which leads to the development of liver steatosis. The role of mTOR signaling in NASH progression to HCC has recently attracted attention. The goals of this review are (1) to highlight recent research on novel genetic and protein contributions to NAFLD\/NASH; (2) to investigate how recent scientific findings might outline the process that causes NASH-associated HCC; and (3) to explore the reliable biomarkers\/targets of NAFLD\/NASH-associated hepatocarcinogenesis.<\/jats:p>","DOI":"10.3390\/cancers15184566","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:06:13Z","timestamp":1694750773000},"page":"4566","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-1450","authenticated-orcid":false,"given":"Anna","family":"Kakehashi","sequence":"first","affiliation":[{"name":"Department of Molecular Pathology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Wanibuchi","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/jvh.13778","article-title":"Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful","volume":"30","author":"Abdelhamed","year":"2023","journal-title":"J. Viral Hepat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: What we need in the future","volume":"38","author":"Araujo","year":"2018","journal-title":"Liver Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/164_2021_561","article-title":"NAFLD and NASH: The Metabolically Diseased Liver","volume":"274","author":"Armandi","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JHC.S347959","article-title":"Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes","volume":"10","author":"Ito","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/15733998113099990068","article-title":"The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: Recent findings and new perspectives","volume":"9","author":"Facciorusso","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: A narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","article-title":"Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity","volume":"7","author":"Loo","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/jcb.30252","article-title":"Contribution of organokines in the development of NAFLD\/NASH associated hepatocellular carcinoma","volume":"123","author":"Vachher","year":"2022","journal-title":"J. Cell Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian. J. Med. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ahmed, E.A., El-Derany, M.O., Anwar, A.M., Saied, E.M., and Magdeldin, S. (2022). Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010210"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kakehashi, A., Stefanov, V.E., Ishii, N., Okuno, T., Fujii, H., Kawai, K., Kawada, N., and Wanibuchi, H. (2017). Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020434"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kakehashi, A., Suzuki, S., Ishii, N., Okuno, T., Kuwae, Y., Fujioka, M., Gi, M., Stefanov, V., and Wanibuchi, H. (2020). Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207746"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Okuno, T., Kakehashi, A., Ishii, N., Fujioka, M., Gi, M., and Wanibuchi, H. (2018). mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans. Cancers, 10.","DOI":"10.3390\/cancers10120465"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/acs.jproteome.1c00965","article-title":"Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma","volume":"21","author":"Ramachandran","year":"2022","journal-title":"J. Proteome Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1038\/emm.2017.175","article-title":"Depletion of S100A4+ stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors","volume":"50","author":"Jiao","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_18","first-page":"909","article-title":"Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease","volume":"3","author":"Wang","year":"2010","journal-title":"Mol. Med. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1126\/science.abp8276","article-title":"Complex regulation of fatty liver disease","volume":"376","author":"Ginsberg","year":"2022","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 Promotes Tumorigenesis via Lipid Synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"120732","DOI":"10.1016\/j.lfs.2022.120732","article-title":"The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions","volume":"305","author":"Alshehade","year":"2022","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Feng, J., Qiu, S., Zhou, S., Tan, Y., Bai, Y., Cao, H., Guo, J., and Su, Z. (2022). mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169196"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1016745","DOI":"10.3389\/fphar.2022.1016745","article-title":"Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41598-023-29135-5","article-title":"Lack of GPR180 ameliorates hepatic lipid depot via downregulation of mTORC1 signaling","volume":"13","author":"Yoshida","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/15548627.2021.1961072","article-title":"Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy","volume":"18","author":"Liu","year":"2022","journal-title":"Autophagy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12672-023-00611-8","article-title":"Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K\/AKT\/mTOR pathway","volume":"14","author":"Wang","year":"2023","journal-title":"Discov. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Kang, J.H., Iqbal, W., and Kwon, O.S. (2015). Proteomic analysis of mice fed methionine and choline deficient diet reveals marker proteins associated with steatohepatitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120577"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"944886","DOI":"10.3389\/fphar.2022.944886","article-title":"Empagliflozin activates Sestrin2-mediated AMPK\/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/bmm-2016-0284","article-title":"Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis","volume":"11","author":"Zhang","year":"2017","journal-title":"Biomark. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.28002","article-title":"A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers","volume":"62","author":"Kamada","year":"2015","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1007\/s00216-016-9878-0","article-title":"Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry","volume":"408","author":"Ji","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Min-DeBartolo, J., Schlerman, F., Akare, S., Wang, J., McMahon, J., Zhan, Y., Syed, J., He, W., Zhang, B., and Martinez, R.V. (2019). Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH). PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226854"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sehgal, P.B. (2022). Interleukin-6 at the Host-Tumor Interface: STAT3 in Biomolecular Condensates in Cancer Cells. Cells, 11.","DOI":"10.3390\/cells11071164"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/iep.12306","article-title":"Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model","volume":"100","author":"Hayashida","year":"2019","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.cmet.2022.10.007","article-title":"MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity","volume":"34","author":"Cheng","year":"2022","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10753-021-01550-8","article-title":"Hepatic Macrophages Express Melanoma Differentiation-Associated Gene 5 in Nonalcoholic Steatohepatitis","volume":"45","author":"Kawaguchi","year":"2022","journal-title":"Inflammation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41467-022-28138-6","article-title":"Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.3350\/cmh.2022.0360","article-title":"Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma","volume":"29","author":"Cho","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lan, Y., Qian, B., Huang, H.Y., Wang, P., Li, T., Yuan, Q., Zhang, H.Y., Lin, Y.C., and Lin, Z.N. (2022). Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911660"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110152","DOI":"10.1016\/j.intimp.2023.110152","article-title":"Leucine aminopeptidase 3:a promising serum biomarker candidate for nonalcoholic steatohepatitis diagnosis","volume":"119","author":"Feng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"118629","DOI":"10.1016\/j.lfs.2020.118629","article-title":"Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD","volume":"264","author":"Liu","year":"2021","journal-title":"Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3748\/wjg.v29.i12.1765","article-title":"Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis","volume":"29","author":"Yao","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","article-title":"p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells","volume":"29","author":"Umemura","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/febs.16317","article-title":"p62\/SQSTM1 in liver diseases: The usual suspect with multifarious identities","volume":"290","author":"Tan","year":"2023","journal-title":"FEBS J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1096\/fj.201601393R","article-title":"Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nsmb.3458","article-title":"CNPY2 is a key initiator of the PERK-CHOP pathway of the unfolded protein response","volume":"24","author":"Hong","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kakehashi, A., Suzuki, S., Shiota, M., Raymo, N., Gi, M., Tachibana, T., Stefanov, V., and Wanibuchi, H. (2021). Canopy Homolog 2 as a Novel Molecular Target in Hepatocarcinogenesis. Cancers, 13.","DOI":"10.3390\/cancers13143613"},{"key":"ref_49","unstructured":"Chen, K.Q., Zhang, Y.Q., Wang, Z.B., and Wang, S.Z. (2023). Progress in Research on CNPY2 in Diseases. Mini Rev. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kakehashi, A., Chariyakornkul, A., Suzuki, S., Khuanphram, N., Tatsumi, K., Yamano, S., Fujioka, M., Gi, M., Wongpoomchai, R., and Wanibuchi, H. (2021). Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. Cancers, 13.","DOI":"10.3390\/cancers13061216"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.32130","article-title":"S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells","volume":"75","author":"Ramani","year":"2022","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","article-title":"Untargeted metabolomics as a diagnostic tool in NAFLD: Discrimination of steatosis, steatohepatitis and cirrhosis","volume":"17","author":"Masarone","year":"2021","journal-title":"Metabolomics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/01635589809514679","article-title":"Direct effect of branched-chain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells","volume":"31","author":"Sugiyama","year":"1998","journal-title":"Nutr. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/jcp.22941","article-title":"Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms","volume":"227","author":"Hagiwara","year":"2012","journal-title":"J. Cell Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"952734","DOI":"10.1155\/2009\/952734","article-title":"PPAR\/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease","volume":"2009","author":"Hardwick","year":"2009","journal-title":"PPAR Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hepres.2005.09.020","article-title":"Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases","volume":"33","author":"Seki","year":"2005","journal-title":"Hepatol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/cancers5041332","article-title":"Oxidative stress in the carcinogenicity of chemical carcinogens","volume":"5","author":"Kakehashi","year":"2013","journal-title":"Cancers"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2006.02.008","article-title":"High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: Comparison to C3H and C57 mice","volume":"246","author":"Iwai","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9508702","DOI":"10.1155\/2021\/9508702","article-title":"Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: A Meta-Analysis of Cohort Study","volume":"2021","author":"Jiao","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"101737","DOI":"10.1016\/j.redox.2020.101737","article-title":"Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2\/M in HepG2 hepatocarcinoma cells","volume":"37","author":"Lagal","year":"2020","journal-title":"Redox Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"van Son, K.C., Verschuren, L., Hanemaaijer, R., Reeves, H., Takkenberg, R.B., Drenth, J.P.H., Tushuizen, M.E., and Holleboom, A.G. (2023). Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers, 15.","DOI":"10.3390\/cancers15041308"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.510300144","article-title":"Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells","volume":"30","author":"Saile","year":"1999","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13550-018-0394-4","article-title":"Evaluation of hepatic integrin alphavbeta3 expression in non-alcoholic steatohepatitis (NASH) model mouse by 18F-FPP-RGD2 PET","volume":"8","author":"Rokugawa","year":"2018","journal-title":"EJNMMI Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3748\/wjg.v25.i19.2279","article-title":"Mechanisms of hepatocellular carcinoma progression","volume":"25","author":"Ogunwobi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The Global Burden of Liver Disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/acs.analchem.9b04578","article-title":"Novel Strategy for Validating the Existence and Mechanism of the \u201cGut-Liver Axis\u201d in Vivo by a Hypoxia-Sensitive NIR Fluorescent Probe","volume":"92","author":"Tian","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"G84","DOI":"10.1152\/ajpgi.00118.2019","article-title":"Role of gut microbiota in liver disease","volume":"318","author":"Albhaisi","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1002\/2211-5463.13272","article-title":"Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways","volume":"11","author":"Abe","year":"2021","journal-title":"FEBS Open Bio"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sugasawa, T., Ono, S., Yonamine, M., Fujita, S.I., Matsumoto, Y., Aoki, K., Nakano, T., Tamai, S., Yoshida, Y., and Kawakami, Y. (2021). One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202105.0136.v1"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"E335","DOI":"10.1152\/ajpendo.00243.2010","article-title":"The metabolic coregulator RIP140: An update","volume":"299","author":"Fritah","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1074\/jbc.273.15.9270","article-title":"Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing","volume":"273","author":"Harnish","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/BJ20070004","article-title":"Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140","volume":"405","author":"Jakobsson","year":"2007","journal-title":"Biochem. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0303-7207(98)00196-8","article-title":"Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor \u03b1","volume":"146","author":"Miyata","year":"1998","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s13277-014-2815-y","article-title":"Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_79","first-page":"144","article-title":"The emerging role of the transcriptional coregulator RIP140 in solid tumors","volume":"1856","author":"Lapierre","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tem.2013.05.001","article-title":"Distinct functions for RIP140 in development, inflammation, and metabolism","volume":"24","author":"Nautiyal","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.0401013101","article-title":"Nuclear receptor corepressor RIP140 regulates fat accumulation","volume":"101","author":"Leonardsson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.febslet.2015.01.001","article-title":"RIP140 triggers foam-cell formation by repressing ABCA1\/G1 expression and cholesterol efflux via liver X receptor","volume":"589","author":"He","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_83","first-page":"8784","article-title":"Downregulation of RIP140 in triple-negative breast cancer inhibits the growth and proliferation of cancer cells","volume":"15","author":"Yu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3892\/or.2017.5551","article-title":"Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF-\u03baB-mediated alternative polarization of macrophages","volume":"37","author":"Hu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbrc.2011.07.048","article-title":"MicroRNA-22 and microRNA-140 suppress NF-\u03baB activity by regulating the expression of NF-\u03baB coactivators","volume":"411","author":"Takata","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e12747","DOI":"10.1111\/nan.12747","article-title":"Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model","volume":"48","author":"Galino","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2022.03.008","article-title":"Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway","volume":"603","author":"Li","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.devcel.2008.10.015","article-title":"UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators","volume":"15","author":"Rutkowski","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxlet.2012.02.017","article-title":"Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model","volume":"211","author":"Lee","year":"2012","journal-title":"Toxicol. Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1091\/mbc.e11-06-0510","article-title":"The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress","volume":"22","author":"Teske","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jb\/mvh122","article-title":"Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II","volume":"136","author":"Yamamoto","year":"2004","journal-title":"J. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"114005","DOI":"10.1016\/j.biopha.2022.114005","article-title":"Induction of autophagy via the PI3K\/Akt\/mTOR signaling pathway by Pueraria flavonoids improves non-alcoholic fatty liver disease in obese mice","volume":"157","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/15548627.2021.1933742","article-title":"Autophagy in metabolism and quality control: Opposing, complementary or interlinked functions?","volume":"18","author":"Deretic","year":"2022","journal-title":"Autophagy"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1556\/OH.2011.29269","article-title":"Role of autophagy in the pathogenesis of liver diseases","volume":"152","author":"Werling","year":"2011","journal-title":"Orv. Hetil."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"108955","DOI":"10.1016\/j.jnutbio.2022.108955","article-title":"Mechanisms of autophagic responses to altered nutritional status","volume":"103","author":"Tao","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Wang, H., Liu, Y., Wang, D., Xu, Y., Dong, R., Yang, Y., Lv, Q., Chen, X., and Zhang, Z. (2019). The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases. Cells, 8.","DOI":"10.3390\/cells8121597"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"109146","DOI":"10.1016\/j.jnutbio.2022.109146","article-title":"Alternate-day fasting prevents non-alcoholic fatty liver disease and working memory impairment in diet-induced obese mice","volume":"110","author":"Zhang","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"102570","DOI":"10.1016\/j.redox.2022.102570","article-title":"Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease","volume":"59","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ccr.2008.02.001","article-title":"The signaling adaptor p62 is an important NF-\u03baB mediator in tumorigenesis","volume":"13","author":"Duran","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e22372","DOI":"10.1096\/fj.202200346R","article-title":"A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma","volume":"36","author":"Green","year":"2022","journal-title":"FASEB J."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Hatta, K., Guo, J., Ludke, A., Dhingra, S., Singh, K., Huang, M.L., Weisel, R.D., and Li, R.K. (2014). Expression of CNPY2 in mouse tissues: Quantification and localization. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111370"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"35412","DOI":"10.1074\/jbc.M306271200","article-title":"MSAP is a novel MIR-interacting protein that enhances neurite outgrowth and increases myosin regulatory light chain","volume":"278","author":"Bornhauser","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2021.01.017","article-title":"Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression","volume":"541","author":"Lo","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.33549\/physiolres.933592","article-title":"Pathophysiological analysis of the progression of hepatic lesions in STAM mice","volume":"66","author":"Saito","year":"2017","journal-title":"Physiol. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1523\/JNEUROSCI.3572-15.2018","article-title":"CACHD1 is an \u03b12\u03b4-like Protein That Modulates CaV3 Voltage-Gated Calcium Channel Activity","volume":"38","author":"Cottrell","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/NCM.0000000000000566","article-title":"Forgetting: The New Normal","volume":"27","author":"Powell","year":"2022","journal-title":"Prof. Case Manag."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.celrep.2018.10.033","article-title":"The \u03b12\u03b4-like Protein Cachd1 Increases N-type Calcium Currents and Cell Surface Expression and Competes with \u03b12\u03b4-1","volume":"25","author":"Dahimene","year":"2018","journal-title":"Cell Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/19336950.2019.1600968","article-title":"CACHD1: A new activity-modifying protein for voltage-gated calcium channels","volume":"13","author":"Stephens","year":"2019","journal-title":"Channels"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bmcl.2009.10.124","article-title":"DNA methylation by dimethyl sulfoxide and methionine sulfoxide triggered by hydroxyl radical and implications for epigenetic modifications","volume":"20","author":"Kawai","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-adenosylmethionine metabolism and liver disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjsurg.2019.09.006","article-title":"Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis","volume":"219","author":"Kwak","year":"2020","journal-title":"Am. J. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/apt.16335","article-title":"Systematic review with meta-analysis: Bariatric surgery reduces the incidence of hepatocellular carcinoma","volume":"53","author":"Ramai","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"101833","DOI":"10.1016\/j.arr.2022.101833","article-title":"Emerging role of aging in the progression of NAFLD to HCC","volume":"84","author":"He","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"101635","DOI":"10.1016\/j.redox.2020.101635","article-title":"Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy","volume":"36","author":"Gao","year":"2020","journal-title":"Redox Biol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Nassir, F. (2022). NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules, 12.","DOI":"10.3390\/biom12060824"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"154768","DOI":"10.1016\/j.phymed.2023.154768","article-title":"Therapeutic application of natural products: NAD+ metabolism as potential target","volume":"114","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ptr.7662","article-title":"Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR\/ULK1-dependent pathway in nonalcoholic fatty liver disease","volume":"37","author":"Zhang","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"102054","DOI":"10.1016\/j.tice.2023.102054","article-title":"AMPK activation by AICAR reduces diet induced fatty liver in C57BL\/6 mice","volume":"82","author":"Krishnan","year":"2023","journal-title":"Tissue Cell"},{"key":"ref_120","first-page":"e220168","article-title":"Cotadutide effect in liver and adipose tissue in obese mice","volume":"70","author":"Oliveira","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"154561","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"154703","DOI":"10.1016\/j.phymed.2023.154703","article-title":"Targeting mTOR\/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation","volume":"113","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Li, J., Kumar, S., Miachin, K., Bean, N.L., Halawi, O., Lee, S., Park, J., Pierre, T.H., Hor, J.H., and Ng, S.Y. (2023). A dual MTOR\/NAD+ acting gerotherapy. bioRxiv.","DOI":"10.1101\/2023.01.16.523975"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"155200","DOI":"10.1016\/j.metabol.2022.155200","article-title":"Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway","volume":"131","author":"Yan","year":"2022","journal-title":"Metabolism"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"101393","DOI":"10.1016\/j.diabet.2022.101393","article-title":"Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus","volume":"49","author":"Wu","year":"2023","journal-title":"Diabetes Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1071415","DOI":"10.3389\/fonc.2023.1071415","article-title":"Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"112697","DOI":"10.1016\/j.biopha.2022.112697","article-title":"Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR\/S6K1\/SREBP-1c signaling pathway","volume":"148","author":"Fan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Oriquat, G., Masoud, I.M., Kamel, M.A., Aboudeya, H.M., Bakir, M.B., and Shaker, S.A. (2023). The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK\/mTOR\/lipogenesis Pathways. Molecules, 28.","DOI":"10.3390\/molecules28041734"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Kim, H.J., You, M., and Kim, H.A. (2022). Red Pepper Seeds Inhibit Hepatic Lipid Accumulation by Inducing Autophagy via AMPK Activation. Nutrients, 14.","DOI":"10.3390\/nu14204247"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.20463\/pan.2022.0006","article-title":"Pharmacological systemic analysis of gardenia fructus against non-alcoholic fatty liver disease and validation of animal models","volume":"26","author":"Lee","year":"2022","journal-title":"Phys. Act. Nutr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/D1FO02481G","article-title":"Steatosis induced by nonylphenol in HepG2 cells and the intervention effect of curcumin","volume":"13","author":"Shan","year":"2022","journal-title":"Food Funct."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s12011-022-03438-6","article-title":"Magnesium Supplementation Stimulates Autophagy to Reduce Lipid Accumulation in Hepatocytes via the AMPK\/mTOR Pathway","volume":"201","author":"Chen","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Zhang, C.Y., Tan, X.H., Yang, H.H., Jin, L., Hong, J.R., Zhou, Y., and Huang, X.T. (2022). COX-2\/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1\/PI3K\/AKT\/mTOR. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158267"},{"key":"ref_134","first-page":"1117","article-title":"Intracerebroventricular injection of ghrelin receptor antagonist alleviated NAFLD via improving hypothalamic insulin resistance","volume":"25","author":"Gong","year":"2022","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"101694","DOI":"10.1016\/j.molmet.2023.101694","article-title":"Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism","volume":"70","author":"Ferguson","year":"2023","journal-title":"Mol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41374-021-00680-9","article-title":"Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice","volume":"102","author":"Yano","year":"2022","journal-title":"Lab. Invest."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.2147\/DMSO.S380053","article-title":"Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway","volume":"15","author":"Tong","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13046-023-02681-6","article-title":"Loss of Ufl1\/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling","volume":"42","author":"Chen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Lynch, E.C., Liu, Z., Liu, L., Wang, X., Zhang, K.K., and Xie, L. (2022). Disrupting Osr1 expression promoted hepatic steatosis and inflammation induced by high-fat diet in the mouse model. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268344"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/jcb.30274","article-title":"Targeting the lysosome: Mechanisms and treatments for nonalcoholic fatty liver disease","volume":"123","author":"Pu","year":"2022","journal-title":"J. Cell Biochem."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Yan, S. (2022). Role of TFEB in Autophagy and the Pathogenesis of Liver Diseases. Biomolecules, 12.","DOI":"10.3390\/biom12050672"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00109-022-02256-6","article-title":"Transcription factor EB inhibits non-alcoholic fatty liver disease through fibroblast growth factor 21","volume":"100","author":"Gong","year":"2022","journal-title":"J. Mol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.1038\/s41598-021-99958-7","article-title":"Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways","volume":"11","author":"Paquette","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41423-022-00872-3","article-title":"Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver","volume":"19","author":"Tang","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10528-020-09971-0","article-title":"Suppression of miR-30a-3p Attenuates Hepatic Steatosis in Non-alcoholic Fatty Liver Disease","volume":"58","author":"Wang","year":"2020","journal-title":"Biochem. Genet."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"903856","DOI":"10.3389\/fmed.2022.903856","article-title":"Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs","volume":"9","author":"Aboud","year":"2022","journal-title":"Front. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"803445","DOI":"10.3389\/fphys.2022.803445","article-title":"MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s42255-022-00616-7","article-title":"Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma","volume":"4","author":"Liu","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Sui, J., Pan, D., Yu, J., Wang, Y., Sun, G., and Xia, H. (2023). Identification and Evaluation of Hub Long Noncoding RNAs and mRNAs in High Fat Diet Induced Liver Steatosis. Nutrients, 15.","DOI":"10.3390\/nu15040948"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2022.06.029","article-title":"LncNONMMUG027912 alleviates lipid accumulation through AMPKalpha\/mTOR\/SREBP1C axis in nonalcoholic fatty liver","volume":"618","author":"Chu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2022.04.008","article-title":"CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis","volume":"610","author":"Xu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2020.03.003","article-title":"MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway","volume":"222","author":"Chen","year":"2020","journal-title":"Immunol. Lett."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4566\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:51:11Z","timestamp":1760129471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":152,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15184566"],"URL":"https:\/\/doi.org\/10.3390\/cancers15184566","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}